Details of the Drug

General Information of Drug (ID: DMFGYZ8)

Drug Name

AR882

Indication

Disease Entry	ICD 11	Status	REF
Gout	FA25	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecule

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04155918) A Phase 2a, Open-Label Study to Evaluate the Safety and Efficacy of AR882 Administered Alone or in Combination With Febuxostat or Allopurinol in Gout Patients. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of Arthrosi Therapeutics